Fusion Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number

Fusion Pharmaceuticals Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 8.21 million shares as of 2024-03-31, per its 10-Q filed 2024-05-07.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2024-05-07

2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 8.21M shares.
2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 7.57M shares.
2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 6.93M shares.
2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 6.38M shares.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
2024-03-31	8.21M shares 10-Q · filed 2024-05-07
2023-12-31	7.57M shares 10-K · filed 2024-03-20
2023-09-30	6.93M shares 10-Q · filed 2023-11-07
2023-06-30	6.38M shares 10-Q · filed 2023-08-08
2023-03-31	5.61M shares 10-Q · filed 2023-05-11
2022-12-31	5.41M shares 10-K · filed 2023-03-16
2022-09-30	4.84M shares 10-Q · filed 2022-11-08
2022-06-30	4.24M shares 10-Q · filed 2022-08-09
2022-03-31	3.70M shares 10-Q · filed 2022-05-10
2021-12-31	3.13M shares 10-K · filed 2022-03-17
2021-09-30	2.81M shares 10-Q · filed 2021-11-09
2021-06-30	2.58M shares 10-Q · filed 2021-08-10
2021-03-31	2.31M shares 10-Q · filed 2021-05-11
2020-12-31	2.05M shares 10-K · filed 2021-03-25
2020-09-30	1.81M shares 10-Q · filed 2020-11-10
2020-06-30	2.08M shares 10-Q · filed 2020-08-11